Brandon Johnson, PhD

Bristol Myers Squibb
New Brunswick, NJ, United States

Sr. Scientist, Translational Medicine, Bristol Myers Squibb

Disclosure information not submitted.

Presentation(s):

• 0584: Non-Clinical Evaluations of Deucravacitinib and Janus Kinase Inhibitor Specificity in Inflammatory or Homeostatic Pathways

  Sunday, November 13, 2022
  9:00 AM – 10:30 AM Eastern Time